Printer Friendly

Browse Tenofovir topic

 

Articles

1-178 out of 178 article(s)
Title Author Type Date Words
Supply Of Tenofovir 245 Mg Tablet. Nov 30, 2017 116
Active Substance Tenofovir, Efavirenz, Emtricitabine. Nov 20, 2017 502
Open House Contracts For Emtricitabine + Tenofovir Disoproxil + Efavirenz. Nov 9, 2017 163
Supply Of Tenofovir 245 Mg. Oct 11, 2017 105
Tab, Tenofovir Disoproxil Fumarate 300 Mg + Lamivudine 300 Mg + Emtricitabine 200 Mg + Efavirenz 600 Mg. Oct 10, 2017 160
Janssen Announces Pivotal Phase 3 Study Results for Investigational Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection in Adults Switching from Boosted Protease Inhibitors Plus Emtricitabine and Tenofovir Disoproxil Fumarate Regimens. Oct 6, 2017 1584
United States : Gilead Presents Results From Phase 3 Study Evaluating Patients Who Switched to Investigational Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide From Boosted Protease Inhibitor-Based Regimens. Clinical report Oct 4, 2017 326
Tab. Lamivudine 300 Mg Plus Tenofovir 300 Mg Plus Efavirenz 600 Mg. Sep 15, 2017 358
Supply Of Tenofovir Disoproxil (doe). Sep 12, 2017 123
Tenofovir Disoproxil, Emtricitabine/tenofovir Disoproxil And Entecavir. Sep 11, 2017 107
Tenofovir Disoproxil Fumarate I.p. 300mg. Tab./cap. Aug 30, 2017 253
Tenofovir 300mg Tab. Aug 28, 2017 157
India : Aurobindo Pharma receives USFDA tentative approval for Dolutegravir. Lamivudine & Tenofovir Disoproxil Fumarate tablets. Aug 22, 2017 158
Tab Tenofovir Disproxil 300 Mg Plus Lamivudine 300 Mg. Aug 22, 2017 114
Aurobindo Pharma gets tentative FDA approval for dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets. Aug 21, 2017 207
Aurobindo Pharma gets tentative FDA approval for dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets. Aug 21, 2017 203
Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a Para. 8 Sgb V On Medicinal Products With The Active Substance Tenofovir Disoproxil (atc Code: J05af07). Aug 18, 2017 511
United States : Gilead Announces U.S. FDA Priority Review Designation for Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for Treatment of HIV. Aug 11, 2017 190
Mylan Receives Tentative Approval for "TLD" Under PEPFAR. Aug 7, 2017 548
Tab. Tenofovir 300mg In Strip Packing. Jul 31, 2017 116
Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study. Zhou, Jing; Liu, Yue-Ying; Lian, Jiang-Shan; Pan, Li-Fang; Yang, Jian-Le; Huang, Jian-Rong Report Jul 27, 2017 4615
Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a Para. 8 Sgb V To The Active Substance Tenofovir Disoproxil, Atc Code: J05af07, For The Period From 1.9.2017 To A Maximum Of 31.8.2019. Jul 21, 2017 127
Completion Of A Non-exclusive Discount Agreement Pursuant To 130a Para. 8 Sgb V Drug Combination Of Tenofovir Disoproxil And Emtricitabine (atc Code: J05ar03) From 01.09.2017 To 31.08.2019. Jul 8, 2017 509
Botulinum Toxin Type A; Deferasirox; Emtricitabine, Tenofovir Disoproxil And Efavirenz; Entecavir; Everolimus; Peginterferon Beta-1a; Rotigotine; Sunitinib; Teriflunomide. Jul 7, 2017 124
Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a Para. 8 Sgb V On The Active Substance Tenofovir Disoproxil + Emtricitabine, Atc J05ar03, For The Period 1.8.2017 - 31.7.2019. Jun 20, 2017 228
Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a Para. 8 Sgb V On The Active Substance Tenofovir Disoproxil, Atc J05af07, For The Period 1.8.2017 - 31.7.2019. Jun 20, 2017 237
Gilead Submits New Drug Application to US FDA for HIV Treatment Combination of Bictegravir, Emtricitabine, and Tenofovir Alafenamide. Jun 13, 2017 191
Open-house Contracts For Emtricitabine + Tenofovir. Jun 5, 2017 119
United States : Gileads Investigational Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for the Treatment of HIV-1 Meets Primary Endpoint in Four Phase 3 Studies. May 31, 2017 302
Gilead Touts Positive Phase 3 Data on Investigational Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for HIV-1. May 31, 2017 213
Tenofovir Disoproxil, Emtricitabine/tenofovir Disoproxil And Entecavir. May 24, 2017 113
Tab Tenofovir 300 Mg. May 13, 2017 117
Mylan wins US FDA's tentative approval for TLE400 for HIV/AIDS under PEPFAR. Mar 21, 2017 243
Mylan wins US FDA's tentative approval for TLE400 for HIV/AIDS under PEPFAR. Mar 21, 2017 239
United States : U.S. Food and Drug Administration approves Gileads Vemlidy (Tenofovir Alafenamide) for the treatment of Chronic Hepatitis B Virus Infection. Nov 15, 2016 491
United States : European CHMP Adopts Positive Opinion for Gileads Vemlidy (Tenofovir Alafenamide, TAF) for the Treatment of Chronic Hepatitis B Virus Infection. Nov 15, 2016 306
Tab. Tenofovir 300 Mg Plus Emtricitabine 200 Mg. Nov 14, 2016 354
Tab. Tenofovir 300 Mg Plus Emtricitabine 200 Mg Plus Efavirenz 600 Mg. Nov 14, 2016 358
United States : European CHMP adopts positive opinion for Gileads Vemlidy (Tenofovir Alafenamide, TAF) for the treatment of chronic hepatitis B virus infection. Nov 12, 2016 307
United States : U.S. Food and Drug Administration approves Gileads Vemlidy (Tenofovir Alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection. Nov 11, 2016 478
Tenofovir Dispoproxil Fumarate300mg With Emtricitabine 200mg And Efavinenz 600mg Tab. Nov 8, 2016 555
Tab / Cap Conataining Lamuvidine 300 Mg Plus Tenofovir 300 Mg Plus Efavarenz 600 Mg. Nov 8, 2016 262
Tab./cap. Containing Tenofovir 300mg In Strip. Nov 8, 2016 255
Tab. Tenofovir 300mg Emitricitabine 200mg Efaverange 600mg. Nov 7, 2016 180
Delivery Of The Drug Tenofovir. Oct 28, 2016 111
Tablet Or Capsule Tenofovir 300 Mg. Oct 14, 2016 352
Tenofovir 300 Mg Tab. Sep 30, 2016 106
Tab Tenofovir 300mg. Sep 21, 2016 207
Drugs Under The Program The Drug Hepatitis : Tenofovir Disoproxil Fumarate. Sep 21, 2016 151
Oxycodone & Naloxone (drug Combination), Tenofovir, Bosentan, Follitropin, Dornase Alfa. Sep 7, 2016 158
Oxycodone & Naloxone (drug Combination), Tenofovir, Bosentan, Follitropin, Dornase Alfa. Aug 27, 2016 156
Tab / Cap Tenofovir 300mg Plus Lamivudine 300mg Plus Efavirenz 600 In Strip Packing. Aug 27, 2016 206
Various Medicinal Products. Aug 26, 2016 120
Cap/tab Tenofovir Disoproxil Fumarate 300mg. Aug 23, 2016 332
Tab. Tenofovir 300 Mg Plus Emtricitabine 200 Mg. Aug 21, 2016 354
Tab. Tenofovir 300mg In Strip Packing. Aug 12, 2016 116
United States : Gileads Odefsey (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) Meets Primary 48-Week Objective in Two Phase 3b Studies. Jul 22, 2016 143
Tenofovir disoproxil fumerate 300 mg lamivudine 300 mg efavirenz 600 mg. Jul 5, 2016 235
Tenofovir may prevent mother-to-child transmission of HBV. Chitnis, Deepak Jul 1, 2016 556
United States : European Commission Grants Marketing Authorization for Gileads Single Tablet Regimen Odefsey (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) for the Treatment of HIV. Jun 24, 2016 681
Tenofovir 300mg plus emtricitabine 200mg plus efavirenz 600mg tab. Jun 16, 2016 134
Tenofovir 300mg and emtricitabine 200mg tab. Jun 15, 2016 131
Supply of Tab Zidovudine 100 Mg, Tab Tenofovir 300 Mg. Jun 11, 2016 128
Event 2623/2016 emtricitabine and tenofovir disoproxil fumarate coated tablets 300mgs + 200 mgs. amparo as no. 223-2012. May 29, 2016 104
Tab. tenofovir disoproxil fumarate 300 mg. May 17, 2016 181
General anti-infectives for systemic use and vaccines. May 7, 2016 173
Adverse effect profile of tenofovir disoproxil fumarate in HIV positive patients--a prospective study. Joseph, Andis C.; Sanalkumar, K.B.; Bharathan, C.S.; Andrews, M.A.; Ajithkumar, K. Report Apr 18, 2016 2928
Efavirenz 600mg , emtricitabine 200mg , tenofovir disoproxil fumarate 300mg tab , bottle of 30 tab. Apr 8, 2016 519
Tenofovir 300mg tab. Apr 7, 2016 120
ContraVir's CMX157 Outperforms Gilead's Tenofovir AF (TAF) Against Hepatitis B Virus in Independent Head-to-Head In-Vitro Study. Mar 29, 2016 861
Tab. tenofovir disoproxil fumarate 300mg. Mar 4, 2016 173
Tablet tenofovir disoproxil fumarate 300 mg. Mar 2, 2016 203
Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China. Wu, Ya-Song; Zhang, Wei-Wei; Ling, Xue-Mei; Yang, Lian; Huang, Shao-Biao; Wang, Xi-Cheng; Wu, Hao; C Mar 1, 2016 3614
Nephrotoxicity during tenofovir treatment: a three-year follow-up study in a Brazilian reference clinic. Neto, Lauro Ferreira da Silva Pinto; Bassetti, Bil Randerson; Fraga, Igor Hernandes Valvassoura; San Report Jan 1, 2016 3094
Efavirenz 600mg with emtricitabine200mg and tenofovir disoproxil fumarate 300mg tab. 30/bott. brand :- viraday. Dec 15, 2015 477
Tab tenofovir disoproxil fumarate 300 mg. Dec 3, 2015 210
On-demand PrEP protects men from HIV infection. Worcester, Sharon Report Dec 1, 2015 803
Efavirenz 600mg with emtricitabine 200mg and tenofovir disoproxil fumarate 300mg tab. 30/bott. brand :- viraday. Nov 24, 2015 478
Drugs in the drug program for hepatitis: tenofovir disoproxil fumarate for the division of infectious diseases and obserwacyjno-liver diseases in healthcare complex in debica. Nov 14, 2015 169
Efavirenz 600mg with emtricitabine 200mg and tenofovir disoproxil fumarate 300mg tab. Oct 14, 2015 475
Tenofovir 300 mg plus emtricitabine 200 mg plus efavirenz 600 mg tablet in strip packing. Sep 8, 2015 430
Bisphosphonates for bone--and advice on ARVs, calcium, vitamin D, glitazones. Mascolini, Mark Report Aug 28, 2015 2824
Tenofovir 300 mg plus emtricitabine 200 mg plus efavirenz 600 mg tablet in strip packing. Aug 19, 2015 430
Tenofovir 300mg tab. Aug 18, 2015 110
Tenofovir 300 mg plus emtricitabine 200 mg plus efavirenz 600 mg tablet in strip packing. Jul 21, 2015 430
Supply of Tenofovir 300mg tab. Jul 17, 2015 104
Urine alphal-microglobulin is a better marker for early tubular dysfunction than beta2-microglobulin among tenofovir-exposed human immunodeficiency virus-infected men who have sex with men. Kang, Jing; Liu, Jing; Ding, Haibo; Li, Xiaolin; Wang, Qi; Guo, Xiaolin; Geng, Wenqing; Shang, Hong Report Jul 1, 2015 5050
Tenofovir 300 mg plus emtricitabine 200mg plus efavirenz 600mg tab. Jun 8, 2015 116
Use of Tenofovir or Entecavir recommended for the treatment of chronic hepatitis B. Apr 15, 2015 624
Mylan Signs Agreement with Gilead to Enhance Access to Tenofovir Alafenamide (TAF)-based HIV Treatments in Developing Countries. Dec 1, 2014 654
Mylan to increase access to Tenofovir Alafenamide (TAF)-based HIV treatments in developing countries. Dec 1, 2014 202
Mylan to increase access to Tenofovir Alafenamide (TAF)-based HIV treatments in developing countries. Dec 1, 2014 198
CKD screening and referring, plus insights on TDF and TAF. Wyatt, Christina M. Interview Sep 22, 2014 2437
Drug tenofovir disoproxil fumarate in hepatitis drug. Sep 2, 2014 109
The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF). Jul 24, 2014 750
The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF). Jul 24, 2014 757
Stability-indicating HPLC method for the simultaneous determination of HIV tablet containing emtricitabine, tenofovir disoproxil fumarate, and rilpivirine hydrochloride in pharmaceutical dosage forms. Venkatesan, S.; Kannappan, N.; Mannemala, Sai Sandeep Report Jan 1, 2014 5289
Update to interim guidance for preexposure prophylaxis (PrEP) for the prevention of HIV infection: prep for injecting drug users. Smith, Dawn K.; Martin, Michael; Lansky, Amy; Mermin, Jonathan; Choopanya, Kachit Jun 14, 2013 2006
Tenofovir alone suffices against lamivudine-resistant hep B. Osterweil, Neil Jan 1, 2013 655
Gilead's Complera[R] Non-Inferior to Atripla[R] Among Treatment-Naove HIV Patients. Clinical report Nov 15, 2012 3131
Gilead's Once-Daily Single Tablet Regimen StribildTM Maintains High Viral Suppression Through Two Years of Therapy Among Treatment-Naove HIV Patients. Nov 15, 2012 3415
Gilead's Once-Daily Novel Prodrug for the Treatment of HIV Meets 24-Week Primary Objective in Phase 2 Study. Oct 31, 2012 2220
U.S. FDA Approves Gilead's StribildTM, a Complete Once-Daily Single Tablet Regimen for Treatment-Naove Adults with HIV-1 Infection. Aug 27, 2012 2193
Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. Smith, D.K.; Thigpen, Michael C.; Nesheim, Steven R.; Lampe, Margaret A.; Paxton, Lynn A.; Samandari Aug 10, 2012 3232
Ranbaxy, Gilead Sciences ink in-licensing pact to promote access to less costly HIV drugs. Aug 3, 2012 315
Mylan Signs Agreement with Gilead to Accelerate Access to Generic Single and Fixed-Dose Combination ARVs Containing Emtricitabine. Aug 2, 2012 700
Approaches to tenofovir and abacavir drug shortages in South Africa: a guide for clinicians. Schowalter, Laurie; Conradie, Francesca Jun 1, 2012 816
The introduction of new antiretroviral-based HIV prevention methods into health systems: an update. Daly, Felicity May 1, 2012 714
Data Show Gilead's Quad Regimen for HIV Non-Inferior to Protease-Based Regimen at 48 Weeks in Second Pivotal Phase 3 Study. Clinical report Mar 9, 2012 1674
Gilead's Quad Single Tablet Regimen for HIV Non-Inferior to Atripla[R] in Pivotal Phase 3 Study. Mar 7, 2012 1632
Low-dose stavudine trials: a public health priority for developing countries. Venter, W.D. Francois; Innes, Steve; Cotton, Mark Report Mar 1, 2012 2153
Vitamin D may improve bone health in those taking anti-HIV drug. Brief article Jan 10, 2012 104
Woman with congenital HIV infection and medication-induced Fanconi syndrome. Mabry, Christian; Kleinpeter, Myra A.; Glancy, D. Luke Clinical report Jan 1, 2012 1678
Knowledge management and collaboration effects: South-South NGO collaboration: a case study on the Brazilian interdisciplinary aids association. Keeney, Grace Case study Jan 1, 2012 11187
Gilead announces EMA validation of MMA for Quad single-tablet regimen for HIV-1 infection. Dec 21, 2011 233
Gilead Files European Marketing Application for the Quad, a Once-Daily Single-Tablet Regimen for the Treatment of HIV Infection. Dec 20, 2011 895
Gilead Sciences Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Truvada[R] for Reducing the Risk of Acquiring HIV. Dec 15, 2011 2992
NIH Discontinues Tenofovir Vaginal Gel in 'VOICE' HIV Prevention Study. Brief article Nov 25, 2011 107
Phase IIIb Comparison of BARACLUDE[R] (entecavir) Monotherapy Versus BARACLUDE Plus Tenofovir Combination Shows No Statistical Difference Between Study Arms. Clinical report Nov 8, 2011 2482
Gilead Submits New Drug Application to U.S. FDA for Once-Daily, Single-Tablet "Quad" HIV Regimen. Oct 27, 2011 960
Mylan Inc wins tentative FDA approval for generic co-packaged drug for HIV/AIDS treatment. Sep 21, 2011 162
Mylan's Matrix gets tentative FDA nod for HIV/AIDS treatment co-pack option. Sep 20, 2011 224
Gilead's Second Pivotal Phase 3 Clinical Study of the Investigational Antiretroviral Quad Regimen Meets 48-Week Primary Objective. Clinical report Sep 19, 2011 1381
Gilead's Investigational Antiretroviral Quad Regimen Meets 48-Week Primary Objective in Pivotal Phase 3 Clinical Study 102. Clinical report Aug 15, 2011 1262
U.S. Food and Drug Administration Approves Gilead Sciences' Complera[TM], a New Complete Once-Daily, Single-Tablet Regimen for HIV-1 Infection in Treatment-Naove Adults. Aug 10, 2011 3656
Tobira Therapeutics Presents Pharmacokinetics and Safety Data that Support Coadministration of Cenicriviroc with Tenofovir DF in Healthy Adults. Jul 19, 2011 717
The risks of concurrent treatment with tenofovir and aminoglycosides in patients with HIV-associated tuberculosis. Kenyon, Chris; Wearne, Nicci; Burton, Rosie; Meintjes, Graeme Case study Apr 1, 2011 2385
Management of HIV-hepatitis B co-infection: Southern African HIV Clinicians Society. Apr 1, 2011 5542
Research and Markets: Tenofovir Comprehensive Patent Search - Eliminate Unnecessary Risk. Feb 9, 2011 514
Gilead Sciences Submits New Drug Application to U.S. FDA for Once-Daily Single-Tablet Regimen of Truvada[R] and TMC278 for HIV. Nov 23, 2010 1701
Antiretroviral gel for prevention of HIV infection in women: phase 2 trial findings. Abstract Nov 1, 2010 294
Viread[R] for Hepatitis B Maintains Antiviral Suppression with No Development of Resistance Through Four Years of Treatment. Oct 30, 2010 3776
Tenofovir gel appears safe during term pregnancy. Brunk, Doug Oct 1, 2010 556
Tenofovir gel effective during term pregnancy. Brunk, Doug Report Sep 15, 2010 531
Gilead's Single-Tablet "Quad" HIV Regimen Maintains High Viral Suppression Through 48 Weeks in Phase II Study. Sep 13, 2010 3791
Tenofovir vaginal gel blocked HIV transmission. Zoler, Mitchel L. Report Sep 1, 2010 786
Antiviral gel promising against HIV: topical treatment cuts infection rates in South African women. Dickey, Gwyneth Report Aug 14, 2010 406
Tenofovir vaginal gel delivers HIV prevention. Zoler, Mitchel L. Aug 1, 2010 839
Chimerix's CMX157 Shows Potential to Treat Multi-Drug-Resistant HIV and Improve the Activity and Toxicity Profile of Tenofovir. Jul 28, 2010 696
Gilead Initiates Phase III Clinical Program Evaluating Single-Tablet, Once-Daily "Quad" Regimen for HIV. Apr 12, 2010 2512
Gilead's Single-Tablet "Quad" Regimen for HIV Achieves a High Rate of Virologic Suppression in Phase II Study. Feb 17, 2010 3441
Gilead Sciences Announces Notification of ANDA Filing for Viread[R]. Jan 28, 2010 541
Gilead announces notification of ANDA filing for Viread. Jan 28, 2010 354
Gilead Sciences Inc (Foster City CA) said top-line results of a mid-stage study showed that its experimental drug regimen to treat HIV infection met the main goal. Brief article Jan 11, 2010 239
Phase II Clinical Trial of Gilead's Investigational Integrase-Based, Once-Daily, Fixed-Dose "Quad" Regimen Meets 24-Week Primary Objective. Jan 6, 2010 2756
Gilead Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread[R] For Chronic Hepatitis B. Oct 31, 2009 2675
Landmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely in Resource-Limited Settings Without Routine Laboratory Monitoring. Clinical report Jul 21, 2009 1702
Gilead Initiates Phase II Clinical Trial of Integrase-Based, Single-Tablet, Once-Daily Regimen for the Treatment of HIV. Apr 17, 2009 2652
Gilead Outlines R&D Priorities for 2009. Jan 27, 2009 1384
Gilead Announces Two-Year Data from Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B. Nov 1, 2008 2877
Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla(R) (Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg) in Twelve Countries. Aug 1, 2008 2058
Tough choices: tenofovir, tenders and treatment. Ford, Nathan; Gray, Andy; Venter, W.D. Francois Jun 22, 2008 2815
Gilead Announces 72-Week Data From Two Pivotal Phase III Studies Evaluating Viread(R) for the Treatment of Chronic Hepatitis B. Apr 24, 2008 2878
Tenofovir beats adefovir at Hep B viral suppression. Sullivan, Michele G. Mar 15, 2008 343
A single dose of tenofovir and emtricitabine can reduce resistance. Farham, Bridget Brief article Jan 1, 2008 233
ATRIPLA(R) - The First and Only Once-Daily Single Tablet HIV Treatment for Virologically Suppressed Adults Available in the UK. Dec 20, 2007 1264
European Commission Approves ATRIPLA(R) (Efavirenz 600 mg/Emtricitabine 200 mg/Tenofovir Disoproxil (as Fumarate) 245 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection. Dec 17, 2007 1036
European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection. Dec 17, 2007 2219
Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe. Dec 11, 2007 2101
European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Oct 18, 2007 2576
Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV. Oct 17, 2007 2168
Gilead Submits Marketing Applications in the United States and European Union for Viread(R) (Tenofovir Disoproxil Fumarate) for the Treatment of Chronic Hepatitis B. Oct 11, 2007 1648
Tenofovir gel--the new HIV prevention 'banker'? Bateman, Chris Jul 1, 2007 1299
Merck & Co., Inc. (1) To Distribute ATRIPLA(TM) in Developing Countries. Feb 16, 2007 3374
Q&A: CDC's clinical studies of pre-exposure prophylaxis for HIV prevention. Drug overview Feb 1, 2007 4716
Gilead Grants Intellectual Property Rights for Tenofovir Topical Gel to the International Partnership for Microbicides and CONRAD. Dec 11, 2006 862
Atripla. Mechcatie, Elizabeth Drug overview Aug 1, 2006 511
Education. Brief article Jun 1, 2006 148
Brazil: Gilead cuts tenofovir price in half. Jan 1, 2006 132
New HIV regimen beats standard combination therapy at 24 weeks. Zoler, Mitchel L. Apr 1, 2005 616
Cambodia stops important tenofovir prevention trial. James, John S. Jul 23, 2004 1029
Atazanavir (Reyataz): new recommendations if combined with tenofovir (Viread)--and warning on Viagra, Cialis, and Levitra. Brief Article Mar 26, 2004 208
Lessons from two "triple nuke" failures (new training module). Brief Article Mar 26, 2004 198
Warning against Tenofovir+ddI+3TC, and "Triple Nuke" combinations. Brief Article Oct 31, 2003 98
HIV drug warning. Worcester, Sharon Brief Article Sep 1, 2003 109
Failure of combination abacavir + tenofovir + lamivudine (3TC). Brief Article Jul 25, 2003 164
Prevention: New approach will test tenofovir for persons at high risk. James, John S. Brief Article Nov 22, 2002 199
Tenofovir approved: Broad indication. James, John S. Brief Article Oct 26, 2001 287

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters